Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01099-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Shi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Central Hospital of Dalian University of Technology, Dalian, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cultivation projects.
Abstract (Originalsprache)
BACKGROUND: Advanced prostate cancer (PCa) displays significant genetic heterogeneity and therapy resistance, yet the role of sensory perception pathways in its progression remains unclear. METHODS: We performed an integrative multi-omics analysis of sensory perception-linked mRNAs and lncRNAs from TCGA and scRNA-seq data. Unsupervised consensus clustering defined three molecular subtypes (CS1-CS3). Key biomarkers were validated in patient tissues and serum. Immune and stromal infiltration were quantified using TIDE and ESTIMATE. Single-cell trajectories characterized TSC22D3-positive T cells, and NicheNet mapped ligand-receptor interactions. RESULTS: Three subtypes emerged, with CS1 showing the poorest prognosis, marked chemotherapy resistance, and pronounced stromal-immune crosstalk. CS1 tumors exhibited elevated B- and T-cell infiltration and increased oxidative phosphorylation in TSC22D3-positive T cells. NicheNet analysis identified the TNF-CCL20 axis as a central mediator of immunosuppressive signaling and chemoresistance in CS1. CONCLUSIONS: This study establishes sensory perception-associated molecular subtypes in PCa and links CS1 chemoresistance to immune microenvironment reprogramming via TNF-CCL20 signaling. These findings offer mechanistic insights into PCa progression and suggest actionable targets to overcome therapeutic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Central Hospital of Dalian University of Technology, Dalian, China.
- Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Urology, Central Hospital of Dalian University of Technology, Dalian, China. drwangwei2008@163.com.
Förderung
- Cultivation projects
Zitieren
APA
Li, S., Tian, Y., Sun, Y., Xu, T., & Wang, W. (2025). Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms. Cellular Oncology. https://doi.org/10.1007/s13402-025-01099-w
Vancouver
Li S, Tian Y, Sun Y, Xu T, Wang W. Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms. Cellular Oncology. 2025. doi:10.1007/s13402-025-01099-w
BibTeX
@article{Li2025,
author = {Li, Shi and Tian, Ye and Sun, Yu and Xu, Tian and Wang, Wei},
title = {Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01099-w}
}
EUVIMED